CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 09/30/2014

Position Statistics

Total Positions 68
New Positions 16
Increased Positions 24
Decreased Positions 13
Positions with Activity 37
Sold Out Positions 4
Total Mkt Value (in $ millions) 619

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 14.95%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 62.07%
Services
Technology
Transportation
Utilities

68 Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
EAGLE PHARMACEUTICALS INC COM 7,764 New 400,000
QUOTIENT LTD SHS 7,725 New 500,000
ALKERMES PLC SHS 7,225 New 100,000
ARRAY BIOPHARMA INC COM 7,160 New 1,000,000
ULTRAGENYX PHARMACEUTICAL INC COM 6,972 New 120,000
PTC THERAPEUTICS INC COM 6,864 -1,373 (16.67) 125,000
KITE PHARMA INC COM 6,715 6,715 New 100,000
ACELRX PHARMACEUTICALS INC COM 6,700 2,010 42.86 1,000,000
NEKTAR THERAPEUTICS COM 6,588 6,588 New 450,000
CHINA BIOLOGIC PRODS INC COM 6,473 -341 (5) 95,000
SANGAMO BIOSCIENCES INC COM 6,395 New 500,000
AUSPEX PHARMACEUTICALS INC COM 6,145 New 100,000
PORTOLA PHARMACEUTICALS INC COM 5,686 New 200,000
ARROWHEAD RESH CORP COM NEW 5,679 New 900,000
HERON THERAPEUTICS INC COM 5,530 New 700,000
IMMUNE DESIGN CORP COM 5,018 5,018 New 200,000
ALNYLAM PHARMACEUTICALS INC COM 4,692 New 50,000
CLOVIS ONCOLOGY INC COM 4,563 New 70,000
GENVEC INC COM NEW 4,506 New 1,329,300
ROCKWELL MED INC COM 4,316 New 400,000